Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2008

01-04-2008 | Research Article

Diabetes care in Norwegian pharmacies: a descriptive study

Authors: Reidun L. S. Kjome, Sverre Sandberg, Anne Gerd Granås

Published in: International Journal of Clinical Pharmacy | Issue 2/2008

Login to get access

Abstract

Objective To describe Norwegian pharmacies’ involvement in diabetes care, to investigate pharmacists’ views on future services and to investigate whether the recommendations in the Norwegian diabetes declaration for pharmacies have been implemented. Setting Hospital and community pharmacies in Norway. Method All 543 pharmacies in Norway, of which 511 were community pharmacies and 32 were hospital pharmacies, received a link to a web-based questionnaire. One pharmacist from each pharmacy was asked to complete the questionnaire. The questionnaire covered subjects ranging from the diabetes declaration and the pharmacists’ views on which services the pharmacy should offer in the future, to demographic characteristics. Results In total 358 (66%) questionnaires were completed. The diabetes declaration was read by 37% of the pharmacists. Almost all pharmacies complied with the declarations’ recommendations regarding glucose monitoring services. Twenty four percent of the pharmacies could offer medication reviews, and roughly 10% could offer screening for undiagnosed diabetes. Counseling on lifestyle issues was the least implemented recommendation. Eighty one percent of the pharmacists reported a wish to expand their services towards diabetes patients. Services in regard to glucose monitoring had the highest score, however the views on which services should be offered varied a great deal. Already performing a service increased the chance of the pharmacist being positive towards offering it. Conclusion Norwegian pharmacists report that they are involved in a wide range of diabetes related services, although only 37% report to have read the diabetes declaration. The pharmacists generally wish to actively support patients with diabetes, and further research should concentrate on identifying the areas where their involvement is most productive.
Literature
1.
go back to reference Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296(4):427–40.PubMedCrossRef Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296(4):427–40.PubMedCrossRef
2.
go back to reference Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001;(1):CD001481. Renders CM, Valk GD, Griffin S, Wagner EH, Eijk JT, Assendelft WJ. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001;(1):CD001481.
3.
go back to reference Intensive diabetes management: implications of the DCCT, UKPDS. Diabetes Educ 2002;28(5):735–40. Intensive diabetes management: implications of the DCCT, UKPDS. Diabetes Educ 2002;28(5):735–40.
4.
go back to reference West D, Blevins MA, Brech D, Stotts F, Gardner S. A multidisciplinary approach in a community pharmacy can improve outcomes for diabetes patients. Diabetes Educ 2003;29(6):962–8.PubMed West D, Blevins MA, Brech D, Stotts F, Gardner S. A multidisciplinary approach in a community pharmacy can improve outcomes for diabetes patients. Diabetes Educ 2003;29(6):962–8.PubMed
5.
go back to reference Schapansky LM, Johnson JA. Pharmacists’ attitudes toward diabetes. J Am Pharm Assoc (Wash ) 2000;40(3):371–7. Schapansky LM, Johnson JA. Pharmacists’ attitudes toward diabetes. J Am Pharm Assoc (Wash ) 2000;40(3):371–7.
6.
go back to reference Johnson JA. Self-efficacy theory as a framework for community pharmacy-based diabetes education programs. Diabetes Educ 1996;22(3):237–41.PubMed Johnson JA. Self-efficacy theory as a framework for community pharmacy-based diabetes education programs. Diabetes Educ 1996;22(3):237–41.PubMed
7.
go back to reference Petkova VB, Petrova GI. Pilot project for education of patients with type 2 diabetes by pharmacists. Acta Diabetol 2006;43(2):37–42.PubMedCrossRef Petkova VB, Petrova GI. Pilot project for education of patients with type 2 diabetes by pharmacists. Acta Diabetol 2006;43(2):37–42.PubMedCrossRef
8.
go back to reference Sarkadi A, Rosenqvist U. Study circles at the pharmacy–a new model for diabetes education in groups. Patient Educ Couns 1999;37(1):89–96.PubMedCrossRef Sarkadi A, Rosenqvist U. Study circles at the pharmacy–a new model for diabetes education in groups. Patient Educ Couns 1999;37(1):89–96.PubMedCrossRef
9.
go back to reference Cranor CW, Bunting BA, Christensen DB. The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43(2):173–84.CrossRef Cranor CW, Bunting BA, Christensen DB. The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43(2):173–84.CrossRef
10.
go back to reference Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30(3):238–43.PubMed Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996;30(3):238–43.PubMed
11.
go back to reference Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the fremantle diabetes study. Diabetes Care 2005;28(4):771–6.PubMedCrossRef Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the fremantle diabetes study. Diabetes Care 2005;28(4):771–6.PubMedCrossRef
12.
go back to reference Snella KA. Pharmacy-and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc (Wash) 2006;46(3):370–7. Snella KA. Pharmacy-and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc (Wash) 2006;46(3):370–7.
13.
go back to reference Krass I, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes J, et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract 2006;75(3):339–47.PubMedCrossRef Krass I, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes J, et al. Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract 2006;75(3):339–47.PubMedCrossRef
14.
go back to reference Granås AG, Berg CL. Type 2-diabetes: Hva kan apotekene bidra med? [type 2 diabetes: what can the pharmacies contribute]. Diabetes Forum 2004;1:36–7. Granås AG, Berg CL. Type 2-diabetes: Hva kan apotekene bidra med? [type 2 diabetes: what can the pharmacies contribute]. Diabetes Forum 2004;1:36–7.
15.
go back to reference Norges Diabetesforbund [homepage on the internet]. The role of Norwegian pharmacies in the prevention and treatment of diabetes. Joint declaration from the Norwegian Diabetes Association, the Norwegian Pharmacy Association and the Interest group Diabetes in the Pharmacy. http://www.diabetes.no/index.asp?id=26256 (27 Jul 2005). Norges Diabetesforbund [homepage on the internet]. The role of Norwegian pharmacies in the prevention and treatment of diabetes. Joint declaration from the Norwegian Diabetes Association, the Norwegian Pharmacy Association and the Interest group Diabetes in the Pharmacy. http://​www.​diabetes.​no/​index.​asp?​id=​26256 (27 Jul 2005).
16.
go back to reference Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: A critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract 2005 2005;(4):231–40.CrossRef Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: A critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract 2005 2005;(4):231–40.CrossRef
17.
go back to reference Lange MH, Granas AG. [Pharmacies before and after the new legislation]. Tidsskr Nor Laegeforen 2003;123(22):3248–49.PubMed Lange MH, Granas AG. [Pharmacies before and after the new legislation]. Tidsskr Nor Laegeforen 2003;123(22):3248–49.PubMed
18.
go back to reference Norges Apotekerforening. Apotek og legemidler 2006 - bransjestatistikk om apotekenes virksomhet og rammevilkår [Pharmacy and drugs 2006]. Oslo: Norges Apotekerforening; 2006. ISBN 82-990739-2-8. Norges Apotekerforening. Apotek og legemidler 2006 - bransjestatistikk om apotekenes virksomhet og rammevilkår [Pharmacy and drugs 2006]. Oslo: Norges Apotekerforening; 2006. ISBN 82-990739-2-8.
20.
go back to reference Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy (New York) 2005;75(1):9–17. Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy (New York) 2005;75(1):9–17.
22.
go back to reference Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990;7(4):360. Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990;7(4):360.
23.
go back to reference Claudi T, Midthjel K, Cooper J, Daae C, Furuseth K, Hanssen KF [monograph on the internet]. NSAMs handlingsprogram for diabetes [NSAMs’ diabetes plan of action]. http://www.nsamdiabetes.no/ (26 Jul 2005) . Claudi T, Midthjel K, Cooper J, Daae C, Furuseth K, Hanssen KF [monograph on the internet]. NSAMs handlingsprogram for diabetes [NSAMs’ diabetes plan of action]. http://​www.​nsamdiabetes.​no/ (26 Jul 2005) .
25.
go back to reference Stewart D, O’Shea J, McCaig D. Agreement of practitioners with the recommendations of the ‘Guidelines for Community Pharmacists on the Care of Patients with Diabetes’. J Soc Adm Pharm 2003;20(1):13–7. Stewart D, O’Shea J, McCaig D. Agreement of practitioners with the recommendations of the ‘Guidelines for Community Pharmacists on the Care of Patients with Diabetes’. J Soc Adm Pharm 2003;20(1):13–7.
26.
go back to reference Westerlund LLTBrH. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother 2006;40(6):1162–9.PubMedCrossRef Westerlund LLTBrH. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother 2006;40(6):1162–9.PubMedCrossRef
27.
go back to reference Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 2005;25(1):96–109.PubMedCrossRef Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy 2005;25(1):96–109.PubMedCrossRef
28.
go back to reference Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai 2005;88(Suppl)4:S134–41.PubMed Suppapitiporn S, Chindavijak B, Onsanit S. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial. J Med Assoc Thai 2005;88(Suppl)4:S134–41.PubMed
29.
go back to reference Masood N, Armour C, Krass I. Identifying potential medication related interventions in type 2 diabetes: a mechanism for enhanced community pharmacy services. J Soc Adm Pharm 2002;19(5):170–9. Masood N, Armour C, Krass I. Identifying potential medication related interventions in type 2 diabetes: a mechanism for enhanced community pharmacy services. J Soc Adm Pharm 2002;19(5):170–9.
30.
go back to reference Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother 2005;39(9):1539–41.PubMedCrossRef Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother 2005;39(9):1539–41.PubMedCrossRef
32.
go back to reference Standards of medical care in diabetes–2006. Diabetes Care 2006; 29(Suppl)1:S4–42. Standards of medical care in diabetes–2006. Diabetes Care 2006; 29(Suppl)1:S4–42.
33.
go back to reference Abduelkarem AR, Sackville MA, Morgan RM, Sackville MP, Hildreth AJ. Views and practices of community pharmacists regarding services for people with type 2 diabetes. Int J Pharm Pract 2003;11:161–8.CrossRef Abduelkarem AR, Sackville MA, Morgan RM, Sackville MP, Hildreth AJ. Views and practices of community pharmacists regarding services for people with type 2 diabetes. Int J Pharm Pract 2003;11:161–8.CrossRef
34.
go back to reference Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc (Wash) 2000;40(6):773–9. Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices among pharmacists. J Am Pharm Assoc (Wash) 2000;40(6):773–9.
35.
go back to reference Heaton PC. Patients’ need for more counseling on diet, exercise, and smoking cessation: results from the National Ambulatory Medical Care Survey. J Am Pharm Assoc 2006;46(3):364–9.CrossRef Heaton PC. Patients’ need for more counseling on diet, exercise, and smoking cessation: results from the National Ambulatory Medical Care Survey. J Am Pharm Assoc 2006;46(3):364–9.CrossRef
36.
go back to reference Younis WS, Campbell S, Slack MK. Pharmacists’ attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother 2001;35(7–8):841–5.PubMedCrossRef Younis WS, Campbell S, Slack MK. Pharmacists’ attitudes toward diabetes and their involvement in diabetes education. Ann Pharmacother 2001;35(7–8):841–5.PubMedCrossRef
37.
go back to reference Storimans MJ, Klungel OH, Talsma H, Bouvy ML, de Blaey CJ. Collaborative services among community pharmacies for patients with diabetes. Ann Pharmacother 2005;39(10):1647–53.PubMedCrossRef Storimans MJ, Klungel OH, Talsma H, Bouvy ML, de Blaey CJ. Collaborative services among community pharmacies for patients with diabetes. Ann Pharmacother 2005;39(10):1647–53.PubMedCrossRef
Metadata
Title
Diabetes care in Norwegian pharmacies: a descriptive study
Authors
Reidun L. S. Kjome
Sverre Sandberg
Anne Gerd Granås
Publication date
01-04-2008
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2008
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-007-9164-5

Other articles of this Issue 2/2008

International Journal of Clinical Pharmacy 2/2008 Go to the issue

Editorial

Editorial

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.